The Latest Cardiac and Vascular News
JACKSONVILLE, Fla. and IRVINE, Calif., March 11, 2019 (GLOBE NEWSWIRE) — Espero BioPharma, Inc., a pharmaceutical company focused on the development of therapeutics for unmet needs in thrombosis and cardiac rhythm control, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for tecarfarin […]
MARLBOROUGH, Mass., March 11, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at EHRA 2019, the annual congress of the European Heart Rhythm Association (EHRA) in Lisbon, Portugal, on March 17-19. Two late-breaking clinical trials will be presented, including: Outcomes from AF-FICIENT I, a prospective, multicenter, single arm […]
STAMFORD, Conn., March 11, 2019 /PRNewswire/ — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Medical Informatics solutions, has partnered with Epsilon Imaging, a revolutionary visualization and analysis software provider for cardiac diagnostic workflow, to expand the advanced analysis capabilities of Fujifilm’s advanced imaging and reporting offering, Synapse® Cardiology PACS. Epsilon Imaging’s […]
AUBURN, Ala. & SHANGHAI–(BUSINESS WIRE)–Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, and Sinotherapeutics Inc., a Shanghai-based generic drug company, announced they have launched a bioequivalent FDA-approved version of Rythmol SR. Rythmol SR, known generically as propafenone hydrochloride, is an antiarrhythmic drug supplied in extended-release capsules of 225, […]
Audio recording: Hakon Bergheim, COO of Adagio Medical speaks with CardiacVascularNews
CHICAGO, March 7, 2019 /PRNewswire/ — Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart sounds accurately to help screen for pathologic heart murmurs and […]
SEATTLE, March 6, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the industry’s first P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, announced it has been selected as a finalist in the fifth annual Impact Pediatric Health Competition to […]
SAN DIEGO–(BUSINESS WIRE)–Sotera Wireless, maker of the ViSi Mobile® Surveillance Monitoring System and a pioneer in continuous vital signs monitoring, announces the availability of its FDA-cleared Life-Threatening Arrhythmia and Atrial-Fibrillation (LTAA) and Fall Detection capabilities with the official launch of ViSi Mobile 1.5G. Previously cleared to monitor continuous noninvasive blood […]
MARLBOROUGH, Mass., March 5, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the first enrollments in a clinical study evaluating use of the HeartLight X3 System in an early persistent AFib patient population. The 60 patient, prospective study will be led […]
SEATTLE, Feb. 28, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it has entered into a distribution agreement with JNC Medical, a distributor of innovative medical technologies based in Ottawa, Ontario. The agreement grants JNC Medical the right to distribute the BardyDx Carnation […]
